HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Zacks Mutual Fund Rank
Did you know that Zacks now ranks mutual funds? We've reinvented the way mutual funds are rated.   Try it now.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Top 10 Stocks
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive


GXDX: Genoptix Inc - Stock Quote Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Quote |  Detailed Quotes |  Real Time |  Options Chain |  Greeks Montage

GENOPTIX INC (NASD)
GXDX 31.34 N/A (N/A%) Vol.  0 N/A ET

Day Low - High N/A - N/A
52wk Low - High 24.15 - 38.13
Avg Volume 349,214
Industry MED-OUTP/HM CRE
Market Cap 536.41 M
Div - Yield 0.00 - 0.00
PE (forward) 16.43
PEG Ratio .64
Current Year Est. 1.9
EPS Last Year 1.60
Detailed Quote


Premium Research: Stock Analysis

Zacks Rank

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Zacks Rank Definition Annualized Return
# 1Buy12%
# 2Strong Sell50.23%
# 3Hold14%
# 4Sell3.97%
# 5Hold1.85%
S&P50012.22%
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank


Short-Term Rating 1-3 Months
PREMIUM
Zacks Recommendation

Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.

The Zacks Recommendations are split into 3 groups: Outperform, Neutral and Underperform. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock. More on these reports below.

Difference Between Zacks Rank and Zacks Recommendation
Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations


Long-Term Rating 6+ Months
PREMIUM
Zacks Industry Rank

Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.

When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

About Zacks Industry Rank
Zacks Industry Rank - All current industry ranks.
Zacks Premium - The only way to get access to the Zacks Industry Rank

PREMIUM
Target Price

The Zacks Price Target provides you our expectation for a stocks share price in the next 6 months. These price targets are created by the Zacks Equity Research group to coincide with their recommendations that are also based on a 6 month time horizon.

Zacks Equity Research Home
Zacks Premium - The only way to get access to the Zacks Price Targets

PREMIUM
Equity Research Report

The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

Zacks Equity Research Home Zacks Premium - The only way to get access to Zacks Recommendations


Updated as of 01/26/2010
PREMIUM
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium

Premium Research: Industry Analysis

Top Peers Ticker Zacks Rank
GENOPTIX INC GXDX PREMIUM
AMSURG CORP AMSG PREMIUM
AMEDISYS INC AMED PREMIUM
CHEMED CORP CHE PREMIUM
See all MED-OUTP/HM CRE Peers

BROKERAGE RECOMMENDATIONS
Current ABR 1.73
ABR (Last Week) 1.73
# of Recs in ABR 11
Average Target Price 42.00
Industry Rank by ABR 128 out of 217
Rank in Industry 14 out of 30
More Brokerage Recommendations

Zacks Community PeopleAndPicks.com
Community Rating

PeopleAndPicks.com Community Stock Ratings

Rating Recommendation % of Stocks
5 stars Strong Buy 10%
4 stars Buy 20%
3 stars Hold 40%
2 stars Sell 20%
1 stars Strong Sell 10%
0 stars Not Rated  

We believe that a community of investors working together can create a superior stock rating system. Some call this "collective intelligence". Or simply...together we can beat the market!

A stock's Community Rating is calculated based on the aggregate input of the PeopleAndPicks Community. The proportion of buy to sell ratings, recency of analysis, and the average score of the users who rate it favorably all factor into a score of one to five stars.


How do you rate GXDX?
Buy
Sell
Find out what the Zacks Community
thinks of GXDX at PeopleAndPicks.com

NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

 Interactive Java Charting
 Comparative Chart



 
ZACKS COMMENTARY FOR GXDX
Zacks Equity Research: Report for GXDX
Jan 26, 2010
Zacks Blog: Genoptix Enters Oversold Territory
Dec 31, 2009
Zacks Blog: Zacks Releases Four Powerful ''Buy'' Stocks: Balchem Corp, Harris Corp., Genoptix, Inc. and Tech Data Corp.
Dec 16, 2009
Momentum: Genoptix, Inc.
Dec 16, 2009
Zacks Blog: Zacks #1 Rank Additions for Wednesday
Sep 23, 2009
Zacks Blog: Zacks #1 Rank Additions for Wednesday
Sep 16, 2009
Zacks Blog: Zacks Industry Rank Analysis Highlights: Healthsouth, Almost Family, AmSurg, DaVita, Emergency Medical Services, Genoptix and LHC Group.
May 14, 2009
Zacks Industry Rank Analysis: Good Numbers for Health Care Providers
May 13, 2009
More Zacks Commentary
NEWS
Genoptix, Momenta Shares Headed for Gains - TheStreet.com
Feb 09, 2010
SmarTrend's Trend Spotter See Continued Downward Momentum on Shares of Genoptix (GXDX)
Feb 08, 2010
Genoptix, Inc. to Announce Fourth Quarter and Full-Year 2009 Financial Results
Feb 04, 2010
SmarTrend's Trend Spotter See Continued Downward Momentum on Shares of Genoptix (GXDX)
Feb 01, 2010
SmarTrend research report available on Genoptix (NASDAQ:GXDX)
Jan 26, 2010
Analyst Downgrades for January 26th
Jan 26, 2010
SmarTrend's Trend Spotter Sees Continued Downward Momentum on Shares of Genoptix (GXDX)
Jan 24, 2010
Genoptix Announces Participation at Jefferies 2010 Global Healthcare Services Conference
Jan 19, 2010
More News
EARNINGS ESTIMATES
  This Quarter
12/2009
Next Quarter
03/2010
This Year
12/2009
Next Year
12/2010
Average Estimate 0.34 0.42 1.63 1.90
Number of Estimates 10 7 10 10
Low Estimates 0.30 0.37 1.58 1.72
High Estimate 0.42 0.46 1.72 2.10
Year Ago EPS 0.30 0.33 1.78 1.63
EPS Growth 14.00% 25.97% -8.15% 16.33%

More Estimates

COMPANY DESCRIPTION
Genoptix is a specialized laboratory service provider focused on delivering personalized and comprehensive diagnostic services to community- based hematologists and oncologists. Genoptix is headquartered in Carlsbad, California.

Full Company Report
FINANCIALS
EPS TTM 1.6
Sales 116.17
Net Income 28.54
Price/Earnings 19.53
Price/Book 3.17
Price/Cash Flow 16.05
Price/Sales 3.17


More Financials

 
About Zacks | Advertise | Affiliate | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2010 Zacks Investment Research